Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
PeproMene Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
PeproMene Bio

PeproMene Bio

Series A

PeproMene Bio: A virtual biotech firm in Irvine, CA, innovating novel immune-oncology therapies.

HQ
Irvine, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

PeproMene Bio, Inc., founded in Irvine, CA, is a clinical-stage biotech company focused on developing innovative immune-oncology therapies. Their core mission is to improve the lives of patients with cancer and immune disorders through novel treatments. The company's flagship product is the BAFF-R CAR-T therapy, which targets the B-cell Activating Factor Receptor (BAFF-R) using a novel antibody. This therapy aims to provide new hope for patients with challenging oncological and immunological conditions.

Notable figures associated with PeproMene Bio include leading scientists and industry experts in the field of immunotherapy. The company has garnered attention from private investors who support its pioneering research. Key achievements include advancing their BAFF-R CAR-T therapy to clinical stages, demonstrating promising potential in preclinical studies. PeproMene Bio's impact lies in its commitment to harnessing cutting-edge science to develop therapies that could significantly alter the treatment landscape for cancer and immune disorders.

PeproMene Bio - Similar Companies

Immpact Bio logo

Immpact Bio

immpact-bio.com

ManaT Bio logo

ManaT Bio

clasptx.com

OncoPep logo

OncoPep

oncopep.com

INmune Bio logo

INmune Bio

inmunebio.com

Minerva Biotechnologies logo

Minerva Biotechnologies

minervabio.com

Petri Bio logo

Petri Bio

petribio.com

Therabiol logo

Therabiol

Dren Bio logo

Dren Bio

drenbio.com

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Epirium Bio logo

Epirium Bio

epirium.com

Immunome logo

Immunome

Inceptor Bio logo

Inceptor Bio

inceptor.bio

Bitterroot Bio logo

Bitterroot Bio

brbio.com

Inimmune logo

Inimmune

inimmune.com

Mongoose Bio logo

Mongoose Bio

mongoosebio.com

PeproMene Bio - Quick Facts

Who are PeproMene Bio's competitors?

Companies similar to PeproMene Bio include Immpact Bio, ManaT Bio, OncoPep and INmune Bio.

When was PeproMene Bio founded?

PeproMene Bio was founded in 2016.

Where is PeproMene Bio's headquarters located?

PeproMene Bio's headquarters is located in Irvine, CA, US.

When was PeproMene Bio's last funding round?

PeproMene Bio's most recent funding round was for $4M (USD) in October 2017.

How much has PeproMene Bio raised to-date?

As of Oct 16, 2017, PeproMene Bio has raised a total of $4M (USD).

How many employees does PeproMene Bio have?

PeproMene Bio has 5 employees as of Feb 5, 2024.

PeproMene Bio - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immune Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified